Market access strategy

Alkemi is a HEOR and market access consulting firm serving pharmaceutical, biotech, medtech, and diagnostics companies as well as private equity firms. It helps life sciences leaders prove the value of treatments, navigate payer requirements, and improve patient access, delivering deployable evidence and access strategies in 90 days or less. The company reports 50+ treatments launched over the past fifteen years and is a certified woman-owned business recognized by Inc. 5000.

advisory boardsBudget impact modelingcost-effectiveness analysisevidence generationHEOR consultingoutcomes researchpayer and HTA submissionsreal-world evidencevalue communications

Anadach Group LLC is a global healthcare strategic consulting firm providing innovative advice and services to clients and partners transforming healthcare systems in emerging markets and developing economies. Since 2009 it has worked across the healthcare sector value chain, with physical offices in the USA and Nigeria and consultants across Africa, the UK, Europe, the Middle East and Asia.

capacity building and trainingclinical governance advisoryfeasibility and due diligence studiesgovernment policy advisoryManagement consultingMarket Researchrecruitmentstrategy consulting

Health 4 Development (H4D) is a consultancy focused on transforming sub-Saharan African healthcare by leveraging private sector innovations, strategies, and methods to support reliable, sustainable access to quality pharmaceuticals and care. It combines African health sector knowledge with a global network of experts and partners, supporting clients across the health value chain.

capacity buildingClinical service delivery optimisationDemand generation and marketingHealth economics and market dynamics analysisInnovative finance structuringProduction operations improvement and technical assistanceSupply chain planning and procurement optimisation

Innopiphany is a women- and minority-owned life sciences strategy consultancy delivering since 2015. It helps life science and medical device companies quantify value, navigate payers, and bring therapies to patients across market access, HEOR, real-world evidence, value policy, patient advocacy, and commercialization, pairing research, health-economic modeling, and advanced analytics with industry insight across the product lifecycle.

Advanced analyticshealth-economic modelingpredictive analyticsreal-world evidence